Get startedLog in
    Picture of Gensight Biologics SA logo

    SIGHT — Gensight Biologics SA News Story

    0.000.00%
    fr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapMomentum Trap
    All News

    Brief: Gensight Biologics: France gives LUMEVOQ(®) Cohort Temporary Authorization for Use

    Picture of Gensight Biologics SA logoGensight Biologics SA
    05/07/2021 06:32
    July 5 (Reuters) - Gensight Biologics SA  SIGHT.PA :
    * GENSIGHT BIOLOGICS ANNOUNCES APPROVAL OF THE LUMEVOQ®
COHORT
TEMPORARY AUTHORIZATION FOR USE (ATUC) IN FRANCE

Source text for Eikon:  ID:nBw8vRLKqa 
Further company coverage:  SIGHT.PA 

 (Reporting by Sudip Kar-Gupta)
 ((sudip.kargupta@thomsonreuters.com;))

    Recent news on Gensight Biologics SA

    See all news